Siga Technologies (SIGA) Net Shares Issued and Repurchased (2020 - 2024)
Siga Technologies' (SIGA) quarterly Net Shares Issued and Repurchased came in at $449722.0 in Q4 2024, up 1461.75% on a YoY basis from $28796.0 in Q1 2024, and up 1461.75% quarter-over-quarter from $28796.0 in Q4 2023.
Analysis
Siga Technologies (SIGA) Net Shares Issued and Repurchased (2020 - 2024) Analysis & Trends
Siga Technologies (SIGA) has reported Net Shares Issued and Repurchased for 5 consecutive years, with $449722.0 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Net Shares Issued and Repurchased rose 1461.75% year-over-year to $449722.0; the trailing twelve-month figure through Dec 2024 stood at $449722.0 (up 1461.75% YoY), and the FY2024 full-year result was $449722.0, up 1461.75% from the prior year.
- Net Shares Issued and Repurchased climbed to $449722.0 in Q4 2024 per SIGA's latest filing, from $28796.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $449722.0 in Q4 2024 and bottomed at $28796.0 in Q4 2023.
- Historically, Net Shares Issued and Repurchased has averaged $151903.6 across 5 years, with a median of $78000.0 in 2020.
- The sharpest annual moves came in 2022 and 2024: Net Shares Issued and Repurchased tumbled 67.32% in 2022, then soared 1461.75% in 2024.
- Over 5 years, Net Shares Issued and Repurchased stood at $78000.0 in 2020, then jumped by 96.15% to $153000.0 in 2021, then sank by 67.32% to $50000.0 in 2022, then slumped by 42.41% to $28796.0 in 2023, then jumped by 1461.75% to $449722.0 in 2024.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $449722.0, $28796.0, and $50000.0 for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -3.07 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 449,722.00 |
| Dec 31, 2023 | 28,796.00 |
| Dec 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Dec 31, 2020 | 78,000.00 |